Ritter Research
Group
Current Research Projects
-
HEART-TSC
Research study to understand the factors that influence rhabdomyoma growth and regression in tuberous sclerosis complex (TSC).
-
TSC-LAM Registry
Clinical study of pregnancy related concerns in women with lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC) or in women with a pregnancy at risk for TSC (for example rhabdomyomas in an infant).
-
Phenotype characterization in TSC
Our team is working on the best way to categorize tuberous sclerosis complex (TSC) related disease processes to be able to predict future concerns in TSC.
-
Early Treatment of TSC with mTOR Inhibitors
We are involved with several studies looking at treatment efficacy and side effects of mTOR inhibitors in TSC and other related disorders.
-
TSC-CARE
TSC-Center for Adult Research Excellence is a project at the Cincinnati Children’s TSC Clinic to improve the care of adults with TSC. In collaboration with physicians at the University of Cincinnati we aim to change how TSC is cared for across the lifespan.
Working to improve care in tSC and related disorders
Our team is working to help understand the broad spectrum of individuals with TSC. We believe that making early diagnoses and understanding the early disease features will help improve outcomes. Our team is based at the Cincinnati Children’s Hospital Medical Center Division of Neurology and University of Cincinnati Department of Pediatrics. Meet the members of our team to see what we are doing.
Papers
Pediatric Neurology. 2024 Dec:161:201-207. doi: 10.1016/j.pediatrneurol.2024.09.023.
Cenobamate is a new medication used for focal seizures. We investigated the improvement of seizures in patients with TSC undergoing treatment with cenobamate.
https://www.pedneur.com/article/S0887-8994(24)00348-5/fulltext
Pediatric Neurology. 2024 Dec:161:73-75. doi: 10.1016/j.pediatrneurol.2024.08.009
Treatment of patients with cenobamate will lower mTOR inhibitor medication levels in patient with TSC.
https://www.pedneur.com/article/S0887-8994(24)00300-X/fulltext
LAUREN C. ALBOR LC, PAUL S. HORN, CHARU VENKATESAN, DAVID M. RITTER
Journal of Child Neurology. 2024. doi:10.1177/08830738241264432
Study looking at the impact of socioeconomic factors and race in missed appointments. This work shows that racial factors supersede socioeconomic factors and suggests that child neurology care is impacted by systemic racism.
https://journals.sagepub.com/doi/10.1177/08830738241264432
Ann Child Neurol Soc, 2: 106-119. doi.org/10.1002/cns3.20070
Phase 1 study of preventative sirolimus treatment in tuberous sclerosis complex. Results show that early treatment with sirolimus is safe and the preliminary efficacy is reassuring.
https://onlinelibrary.wiley.com/doi/10.1002/cns3.20070
Andrew Dhawan, Sarah Baitamouni, Darren Liu, Robyn Busch, Patricia Klaas, Thomas W. Frazier, Siddharth Srivastava, Sumit Parikh, Gary E. Hsich, Neil R. Friedman, David M. Ritter, Antonio Y. Hardan, Julian A. Martinez-Agosto, Mustafa Sahin, Charis Eng
A study investigating the neurologic phenotype within a consortium of sites investigating PTEN Hamartoma Tumor Syndrome.
https://onlinelibrary.wiley.com/doi/10.1002/acn3.52046
MEREDITH ROSE, DAVID RITTER, NISHANT GUPTA, LEANDRA TOLUSSO, PAUL HORN, EMILY WAKEFIELD & JENNIFER GLASS
Provider survey showing that providers view pregnancy with TSC as higher risk than normal. However, there is a wide variety of opinions about what should be done and how to manage mTOR inhibitors during the pregnancy. We suggest the development of consensus statements from experts in the field to help guide pregnancy care.
https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-03015-7
Durgesh Tiwari, Valerine Rajathi, Jeffrey K Rymer, Lindsay N Beasley, Amanda M McGann, Alexander T Bunk, Emma V Parkins, McKenzie F Rice, Katie E Smith, David M Ritter, Angela R White, Carolyn M Doerning, Christina Gross
Laboratory investigation showing that estradiol and progesterone alter microRNAs involved in the regulation of seizures. Specifically microRNAs regulating Kv4.2 channel function are controlled by hormonal changes. This has impact on the interpretation of animal models of seizures, treatment possibilities, and catamenial epilepsy.
https://www.eneuro.org/content/10/7/ENEURO.0047-22.2023
David M Ritter, Bailey K Fessler, Daniel Ebrahimi-Fakhari, Jun Wei, David N Franz, Darcy A Krueger, Andrew T Trout, Alexander J Towbin
MRI and CT findings in patients with TSC of all ages. Some findings were increased over typical population findings. Most increased with age, however renal cysts decreased with age. Interestingly, I large percentage of males who had CT images also had TSC-related lung disease findings.
https://ojrd.biomedcentral.com/articles/10.1186/s13023-022-02277-x
KAREN AGRICOLA, GABRIELLE STIRES, DARCY A KRUEGER, JAMIE K CAPAL, DAVID N FRANZ, DAVID M RITTER
Case series of patients who developed diabetes after mTOR inhibitors. Importantly, it is not a high number of patients and those who developed it often had other medication-related risk factors. Nearly all patients can be treated without stopping mTOR inhibitors.
https://www.sciencedirect.com/science/article/pii/S0887899421000539
RICHARD J TAYLOR, DAVID M RITTER, MARIA E FRAZIER, MATTHEW W ZACKOFF
Case presentation of a young girl with tick paralysis.
https://publications.aap.org/pediatricsinreview/article/42/6/329/179834/Acute-Ataxia-and-Paresthesia-in-a-Healthy-5-year
DAVID M. RITTER, CIUXIA TIAN, AND EILEEN BROOMALL
Case report of the presentation and treatment of a patient with severe SCN4a-induced crisis.
https://onlinelibrary.wiley.com/doi/10.1002/mus.27237
DAVID M. RITTER, PAUL S. HORN, AND KATHERINE D. HOLLAND
Study looking at models to predict KCNQ channel pathogenicity and their accuracy. We determined a modified algorithm that was both specific and sensitive for KCNQ related epilepsy.
https://www.sciencedirect.com/science/article/pii/S0887899421000072
DAVID M. RITTER AND KATHERINE HOLLAND
Review article on the role of genetic testing in epilepsy patients. Additionally, a work flow for deciding on testing was proposed.
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0040-1719070
BENJAMIN M ZEMEL, DAVID M RITTER, MANUEL COVARRUBIAS, TANZIYAH MUQEEM
Review article describing the roles of various “A-type” potassium channels in the dorsal root ganglion including Kv1.4, Kv3.4, Kv4.2 and Kv4.3 channels.
https://www.frontiersin.org/articles/10.3389/fnmol.2018.00253/full
DAVID M RITTER, COJEN HO, MICHAEL E O'LEARY, MANUEL COVARRUBIAS
Work shows that’s a specific potassium channel, Kv3.4, is important for regulating the action potential (electrical signals) in pain-sensing neurons.
https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/jphysiol.2011.218560
Jeffrey D Fineberg, David M Ritter, Manuel Covarrubias
A study showing that experimentally different ion channels inactivate via different mechanisms. The role of these inactivation mechanisms was then determined in an model neuron.
https://rupress.org/jgp/article/140/5/513/43084/Modeling-independent-elucidation-of-inactivation
DAVID M RITTER, BENJAMIN M ZEMEL, TAMARA J HALA, MICHAEL E O'LEARY, ANGELO C LEPORE, MANUEL COVARRUBIAS
Here we showed that different phenotypes of Kv3.4 channel inactivation correlate with variable states following spinal cord injury. We propose that these different channel phenotypes underlie chronic pain responses.
https://www.jneurosci.org/content/35/3/1260.long
DAVID M RITTER, BENJAMIN M ZEMEL, ANGELO C LEPORE, MANUEL COVARRUBIAS
Kv3.4 channels are expressed in nociceptors regardless of species and sex. Additionally, their role in electrical signals can be modeled accurately and shown with toxins.
https://www.tandfonline.com/doi/full/10.1080/19336950.2015.1056949
Contact Us
Reach out to our research team with any questions you may have. Of note, currently we are not looking to hire any research team members.